SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-24-099432
Filing Date
2024-09-12
Accepted
2024-09-12 20:45:53
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2423966d1_sc13d.htm SC 13D/A 26904
  Complete submission text file 0001104659-24-099432.txt   28599
Mailing Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139
Business Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Dianthus Therapeutics, Inc. /DE/ (Subject) CIK: 0001690585 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90538 | Film No.: 241296222
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2001 MARKET STREET, SUITE 2500 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET, SUITE 2500 PHILADELPHIA PA 19103 1-267-760-4066
Viridian, LLC (Filed by) CIK: 0001761506 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A